查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1542860

全球生物医学嵌入式系统市场 - 2024-2031

Global Biomedical Embedded Systems Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

全球生物医学嵌入式系统市场在2023年达到1.7025亿美元，预计到2031年将达到3.4874亿美元，在2024-2031年预测期间复合年增长率为9.7%。

生物医学嵌入式系统是整合硬体和软体组件的电子系统，用于监测、诊断和管理人类健康的各个方面。这些系统由微控制器、感测器和其他组件组成，共同收集和处理生理资料。它们嵌入到穿戴式装置、植入装置和诊断工具等医疗设备中，从而实现即时资讯传递、提高准确性并改善患者治疗结果。

市场动态：

驱动程式和限制

慢性病盛行率上升

近年来，随着慢性病的兴起，对诊断、预后和患者管理等远距医疗应用的需求日益增长。嵌入式系统技术已在生物医学技术中占有重要地位。特别是开发工具，以在大流行等过程中发生流行性传染病时提高医护人员的安全。

例如，根据美国疾病管制与预防中心 (CDC) 统计，到 2024 年，美国将有 1.29 亿人患有至少一种主要慢性疾病，包括心臟病、癌症、糖尿病、肥胖和高血压。美国十大死亡原因中有五个与可预防和可治疗的慢性病有关。

在过去的二十年里，盛行率稳定上升，这种趋势预计将持续下去。越来越多的美国人患有多种慢性病，其中 42% 的人患有两种或两种以上，12% 的人患有至少五种慢性病。慢性病也对美国医疗保健系统产生重大影响，占年度 4.1 兆美元支出的 90%。

嵌入式系统容易遭受安全漏洞和网路威胁

阻碍产业成长的关键因素之一是嵌入式设备的安全性。军队、银行、资料中心和医疗机构都依赖嵌入式设备（包括记忆体）来保留潜在的关键资讯。因此，必须不惜一切代价避免网路安全风险和违规行为。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

  • 影响因素
    • 司机
      • 慢性病盛行率上升
      • 设备的进步
    • 限制
      • 嵌入式系统容易遭受安全漏洞和网路威胁
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 专利分析
  • 大环境分析
  • SWOT分析
  • DMI 意见

第 6 章：按组件

  • 软体
  • 硬体

第 7 章：按申请

  • 穿戴式装置
  • 植入式装置
  • 诊断设备
  • 治疗设备

第 8 章：最终用户

  • 医院
  • 诊所
  • 家庭护理设置
  • 其他的

第 9 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 11 章：公司简介

  • Medtronic plc
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Philips Healthcare
  • Siemens Healthineers
  • General Electric (GE) Healthcare
  • Roche Diagnostics
  • Johnson & Johnson
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Texas Instruments
  • Analog Devices

第 12 章：附录

简介目录
Product Code: MD8591

Overview

Global Biomedical Embedded Systems Market reached US$ 170.25 million in 2023 and is expected to reach US$ 348.74 million by 2031, growing at a CAGR of 9.7% during the forecast period 2024-2031.

Biomedical embedded systems are electronic systems that integrate hardware and software components to monitor, diagnose, and manage various aspects of human health. These systems, consisting of microcontrollers, sensors, and other components, work together to collect and process physiological data. They are embedded in medical devices like wearables, implantables, and diagnostic tools, enabling real-time information delivery, enhanced accuracy, and improved patient outcomes.

Market Dynamics: Drivers & Restraints

Rise in the prevalence of chronic diseases

In recent years, with the rise of chronic diseases, there has been a growing need for telemedicine applications such as diagnosis, prognosis, and patient management. Embedded system technologies have occupied an important area in biomedical technology. Especially, to develop tools for the purposes of increasing the safety of healthcare workers in the event of epidemic infectious diseases in processes such as pandemics.

For instance, according to the CDC, in 2024, the US has 129 million people with at least one major chronic disease, including heart disease, cancer, diabetes, obesity, and hypertension. Five of the top 10 leading causes of death in the US are associated with preventable and treatable chronic diseases.

Over the past two decades, prevalence has steadily increased, and this trend is expected to continue. An increasing proportion of Americans are dealing with multiple chronic conditions, with 42% having two or more and 12% having at least five. Chronic diseases also significantly impact the US healthcare system, accounting for 90% of annual $4.1 trillion expenditure.

Vulnerability of embedded systems to security breaches and cyber threats

One of the key factors slowing industry growth is the security of embedded devices. Military forces, banks, data centers, and healthcare facilities all rely on embedded devices, including memory, to retain potentially critical information. As a result, cybersecurity risks and breaches must be avoided at all costs.

Segment Analysis

The global biomedical embedded systems market is segmented based on component, application, end-user, and region.

The software from the component segment accounted for approximately 54.1% of the biomedical embedded systems market share

Software is a vital component in the biomedical embedded systems market, enhancing the functionality and efficiency of medical devices. It integrates complex algorithms and data processing capabilities, managing and interpreting medical data, controlling hardware components, and ensuring real-time responsiveness.

Software also aids in the development of advanced diagnostics, monitoring, and therapeutic solutions, while supporting regulatory compliance and security measures. As technology advances, software continues to drive innovation and improve the accuracy and reliability of biomedical embedded systems.

For instance, in November 2023, SolidWorld Group S.p.A. upgraded its Electrospider, the first three-dimensional bioprinter capable of replicating human cell tissue, with the incorporation of advanced proprietary Artificial Intelligence. This technological advancement represents a significant step in the future of biomedical engineering.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to advancements in healthcare technology and increasing demand for advanced medical devices. The region benefits from a strong healthcare infrastructure, high investment in research and development, and a robust presence of leading medical technology companies. Innovations like wearable health monitors, advanced diagnostic tools, and remote patient management systems are crucial for personalized healthcare and improving patient outcomes. North American regulations promote high-quality, safe, and reliable medical devices.

Market Segmentation

By Component

  • Software
  • Hardware

By Application

  • Wearable Devices
  • Implantable Devices
  • Diagnostic Devices
  • Therapeutic Devices

By End User

  • Hospitals
  • Clinics
  • Home care settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the market include Medtronic plc, Philips Healthcare, Siemens Healthineers, General Electric (GE) Healthcare, Roche Diagnostics, Johnson & Johnson, Abbott Laboratories, Boston Scientific Corporation, Texas Instruments, Analog Devices among others.

Key Developments

  • In January 2022, Onera Health announced the introduction of its first Onera Biomedical-Lab-on-Chip. The biomedical sensor system-on-chip acquires and processes multiple biosignals and is designed for a broad range of wearable health applications and devices, offering many solutions and opportunities for innovation in the medical, wellness, and fitness space.

Why Purchase the Report?

  • To visualize the global biomedical embedded systems market segmentation based on component, application, end-user, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the biomedical embedded systems market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global biomedical embedded systems market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Component
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the prevalence of chronic diseases
      • 4.1.1.2. Advancements in the devices
    • 4.1.2. Restraints
      • 4.1.2.1. Vulnerability of embedded systems to security breaches and cyber threats
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Patent Analysis
  • 5.6. PESTLE Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Component

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 6.1.2. Market Attractiveness Index, By Component
  • 6.2. Software*
    • 6.2.1. Introduction
  • 6.3. Hardware

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.2. Market Attractiveness Index, By Application
  • 7.3. Wearable Devices*
    • 7.3.1. Introduction
    • 7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.4. Implantable Devices
  • 7.5. Diagnostic Devices
  • 7.6. Therapeutic Devices

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Clinics
  • 8.4. Home care settings
  • 8.5. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Medtronic plc*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Philips Healthcare
  • 11.3. Siemens Healthineers
  • 11.4. General Electric (GE) Healthcare
  • 11.5. Roche Diagnostics
  • 11.6. Johnson & Johnson
  • 11.7. Abbott Laboratories
  • 11.8. Boston Scientific Corporation
  • 11.9. Texas Instruments
  • 11.10. Analog Devices

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us